News | October 24, 2012

Varian Medical Systems Receives Clearance to Market the Unique Radiotherapy System in China

Radiation Therapy Varian UNIQUE China

October 24, 2012 — Varian Medical Systems Inc., manufacturer of medical technology for treating cancer with radiotherapy, announced that China's State Food and Drug Administration (SFDA) has granted clearance to market the UNIQUE medical linear accelerator, a single-energy machine for treating cancer with advanced forms of image-guided radiotherapy. The versatile UNIQUE system can be used to deliver intensity-modulated radiotherapy (IMRT) and RapidArc treatments, which precisely target tumors while minimizing exposure of surrounding healthy tissues.

The UNIQUE radiotherapy system is the world's first low-energy (6MV) radiotherapy system that can be outfitted with high-tech image-guidance, beam shaping, and RapidArc technology for rapid treatment delivery. It also includes the latest release of Varian's market leading Eclipse treatment planning software, offering clinicians a seamless workflow for planning and delivering advanced radiotherapy treatments. It is a cost effective solution designed to make access to quality care more widely available to cancer patients around the world.

"Epidemiological data show that more than 2.2 million new cancer cases are diagnosed in China each year," said Tom Duffy, head of Varian's Oncology Systems business in Asia. "This presents the dedicated clinicians in China with daunting numbers of patients in need of treatment. Many departments operate two or three shifts to keep up with the demand for access to radiotherapy treatment. In recognition of the challenge, the Chinese Ministry of Health has announced a dramatic increase in the number of licenses available to hospitals for the purchase of additional accelerators. Varian created the UNIQUE system to help address the need for greater access to care in China and other parts of the world."

The UNIQUE system can be used to deliver RapidArc radiotherapy, an arc-based approach that makes it possible to complete an image-guided IMRT treatment in a matter of minutes — up to four times faster than is possible with conventional IMRT.

The UNIQUE system is ideally equipped for treating cancer of the head and neck, breast, cervix, lung, prostate and other tumors. It is available in two configurations: UNIQUE Performance Edition, which incorporates all the tools needed for image-guided RapidArc radiotherapy, and UNIQUE Power Edition, a more basic platform that can be upgraded at a later time. Either package is ideal for treatment centers looking to transition from older cobalt units to modern radiotherapy technology. The small footprint of the UNIQUE accelerator allows it to fit into most small, existing treatment vaults.

For more information: www.varian.com

Related Content

New Prostate Cancer Radiotherapy Technique Aims to Preserve Sexual Function
News | Radiation Therapy | June 18, 2018
A multicenter clinical trial being led by UT Southwestern physicians is testing a technique for sparing nerve bundles...
Elekta Unity High-Field MR-Linac Receives CE Mark
News | Image Guided Radiation Therapy (IGRT) | June 18, 2018
Elekta announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has received CE mark,...
Washington University in St. Louis Begins Clinical Treatments With ViewRay MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | June 14, 2018
June 14, 2018 — The Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in S
Accuray TomoTherapy System Beneficial in Two Total Body Irradiation Studies
News | Radiation Therapy | June 13, 2018
Recently published data from two new studies demonstrate the benefits of Accuray’s TomoTherapy System in the delivery...
IsoRay Funding Brain Cancer Treatment Research With Ochsner Clinic Foundation
News | Brachytherapy Systems | June 12, 2018
IsoRay Inc. announced the initiation of research funding for brain cancer treatment to Ochsner Clinic Foundation, a not...
News | Brachytherapy Systems | June 07, 2018
IsoRay Inc. announced the upcoming release of its Build-Blu delivery system for real-time prostate brachytherapy.
Raysearch RayStation
Feature | Radiation Therapy | June 05, 2018 | By Melinda Taschetta-Millane
Treatment planning systems are at the heart of r...
Beaumont Researchers Invent New Mode of Proton Treatment for Lung Cancer
News | Proton Therapy | May 31, 2018
Members of Beaumont Health’s proton therapy team presented research on a new treatment for patients with lung cancer at...
More Than 60 Percent of Patients Seeking Proton Therapy Initially Denied Coverage
News | Proton Therapy | May 25, 2018
The Alliance for Proton Therapy Access has released a national report revealing the heavy emotional and financial...
News | Treatment Planning | May 24, 2018
Daniela Schmitt, Ph.D., took top honors in the overall category of the 2018 TROG Plan Study: Stereotactic Radiosurgery...
Overlay Init